November Monthly Price Drop: ₹80,000 all-inclusive until 16 November, 11:59 PM IST. 52% off.|Foresight ₹1,40,000 ₹67,797 + 18% GST|12 months of accessGet Foresight
All board jobs

Applications closed

This seat is no longer taking applications — closed on 14 September 2026.

The brief stays here for reference. Seats like it open every week.

See live board seats
India ID Exchange Private-company listingPE/VC-Backed Company Governance

Independent Director — Renal Care Network | Clinical Outcomes, PPP Governance and Unit Economics

Confidential private-equity-backed renal-care network Hyderabad· Renal Care & Dialysis Services
Clinical QualityAuditRisk

Closed 14 September 2026

Company: Confidential private-equity-backed healthcare network
Board base: Hyderabad, Telangana
Sector: Dialysis and chronic renal care
Appointment: Independent Director, Non-Executive
Intended committees: Clinical Quality & Patient Safety Committee Chair; member, Audit and Risk Committees
Time commitment: 28–35 days annually, including centre and government-contract reviews
Application deadline: 29 September 2026
Expected appointment: December 2026

Company context

The platform provides haemodialysis and related renal-care services through standalone centres, hospital partnerships and public-private programmes. It serves recurring patients who depend on reliable treatment several times each week. Growth combines new centres, government tenders, hospital outsourcing and acquisition of regional operators.

Market hint: A sponsor-backed network with meaningful government-scheme exposure, hub procurement and a mix of hospital and standalone centres may suggest several renal-care platforms. Centre count, sponsor and state contracts are withheld.

Board mandate

The director will ensure that recurring-care economics never compromise infection control, treatment adequacy, staffing or patient continuity. The Board must see clinical and cash performance at the same centre-and-cohort level.

Strategic priorities

  1. Define outcome measures covering treatment adequacy, vascular access, infection, hospitalisation, missed sessions, mortality, anaemia management and patient-reported experience, adjusted for case mix.
  2. Establish water-treatment, machine-disinfection, dialyser, medication, emergency and consumable critical controls with independent verification.
  3. Track staffing, nephrologist coverage, technician competence, nurse ratios, fatigue, agency labour and escalation capability by shift and centre.
  4. Review PPP and government contracts for eligibility, package economics, claims evidence, rejection, payment delay, consumables, staffing and termination risk.
  5. Protect patient continuity during hospital disputes, centre closure, supply disruption, flood, cyber outage or delayed government payment.
  6. Examine centre economics after occupancy, staffing, nephrologist cost, rent, maintenance, water, consumables, bad debt and central allocation.
  7. Set new-centre gates based on patient density, referral dependence, emergency transfer, licence readiness, working capital and time to safe scale.
  8. Govern procurement and reuse policies for dialysers, bloodlines, concentrates, drugs and imported machines through safety, traceability and conflicts.
  9. Require acquisition diligence on outcomes, infection, water, contracts, cash, clinician relationships, equipment, licences and incident history.
  10. Protect patient data, schedule integrity and clinical continuity during technology deployment.

Decisions expected at Board level

  • Whether a government contract should continue when payment delays threaten safe service.
  • Whether a centre with recurring infection indicators should pause treatment and transfer patients.
  • Whether a hospital partner provides adequate emergency support for a new unit.
  • Whether an acquisition’s reported EBITDA survives clinical and equipment remediation.
  • Whether cost reduction in consumables or staffing crosses a patient-safety boundary.

Candidate profile

Essential: Former dialysis, hospital, chronic-care, medical-device or healthcare-network CEO/COO/CFO/clinical leader, healthcare investor or regulator; multi-site clinical governance; PPP or reimbursement economics; acquisition and patient-continuity judgement.

Preferred: nephrology, infection prevention, water systems, government health schemes, healthcare buy-and-build, Audit Committee experience.

Eligibility and conflicts

Active IICA registration and verified test/exemption status are mandatory for this search. Candidates must disclose hospital, nephrologist, government-contract, equipment, consumable, pharmaceutical, insurer, laboratory, investor, auditor and acquisition-target relationships.

First-year outcomes

  • Comparable centre-level clinical and financial performance.
  • Verified infection, water and emergency critical controls.
  • PPP decisions based on full cash and patient-continuity risk.
  • Acquisition gates integrating clinical remediation and return.
  • Tested continuity for centre, supplier and technology disruption.

New to Pharma & Healthcare boards?

What these boards look for, how the committees are composed, what the seats pay, and the eligibility rules that apply.

Seats like this, open now

India ID ExchangeMedium Term

Audit Committee Chair — Digital Trust, Revenue Integrity and Platform Resilience

Confidential listed technology and trust-services company Mumbai· Technology and Digital Services
Current Listing Foresight Priority PeriodAudit Committee Chair & Financial Expert First-timer eligibilityForesight shows whether this board will consider a first-time independent director, before you spend an application.Click to get Foresight →AuditNRCCSR

The business delivers technology and trust-sensitive services. Its financial result depends on contracts, platform availability, protected information, customer acceptance and continuing service obligations. The Audit Committee Chair must therefore examine not only whether the…

Compensation status with ForesightForesight shows when compensation is not disclosed and provides a labelled benchmark where one is available.Click to get Foresight →
Apply with a free account
Applications close in 43d 17:37:09· 29 December 2026 at 11:59 pm IST
Posted 30 OctApply
India ID ExchangeMedium Term

NRC Chair and Risk Member — Listed Specialist Finance Institution

Confidential listed specialist finance institution Delhi NCR· Banking and Financial Services
Current Listing Foresight Priority PeriodSector-Regulated Independent DirectorNRCRiskStakeholders

The independent director will chair NRC and serve on Risk, Stakeholders Relationship and CSR. The mandate is to ensure that leadership, incentives and succession can withstand the institution's aggregate risk before individual businesses use their own metrics to explain it away.…

Compensation status with ForesightForesight shows when compensation is not disclosed and provides a labelled benchmark where one is available.Click to get Foresight →
Apply with a free account
Applications close in 42d 17:37:09· 28 December 2026 at 11:59 pm IST
Posted 30 OctApply
India ID ExchangeMedium Term

NRC Chair — Process Manufacturing, Succession and Long-Horizon Capability

Confidential listed process-manufacturing company Noida· Process Manufacturing
Current Listing Foresight Priority PeriodNRC Chair & Board SuccessionNRC

The company combines process engineering, manufacturing, resource stewardship, supply networks and customer relationships that mature over long cycles. The NRC Chair must ensure that leadership succession and reward preserve capability across cycles rather than optimise only the…

Compensation status with ForesightForesight shows when compensation is not disclosed and provides a labelled benchmark where one is available.Click to get Foresight →
Apply with a free account
Applications close in 41d 17:37:09· 27 December 2026 at 11:59 pm IST
Posted 29 OctApply
India ID ExchangeMedium Term

NRC Chair and Risk Member — Financial Markets Leadership and Conduct

Confidential listed financial-services company Mumbai· Banking and Financial Services
Current Listing Foresight Priority PeriodNRC Chair & Board SuccessionNRCRiskAudit

The seat chairs NRC and participates in Risk and Audit. The Board needs a director who can judge whether leadership, incentives and control-function stature support fiduciary conduct through changing markets. In financial services, stakeholder confidence can alter flows,…

Compensation status with ForesightForesight shows when compensation is not disclosed and provides a labelled benchmark where one is available.Click to get Foresight →
Apply with a free account
Applications close in 39d 17:37:09· 25 December 2026 at 11:59 pm IST
Posted 28 OctApply